Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HMSC- A simple breast cancer screening device -- Ignore unavailable to you. Want to Upgrade?

To: Master (Hijacked) who wrote (220)	6/24/1998 5:11:00 PM
From: Jason Loren Bauer	Read Replies (2) \| Respond to of 246

NEWS Wednesday June 24, 4:05 pm Eastern Time Company Press Release SOURCE: HumaScan Inc. HumaScan Inc. Retains Physicians World Communications Group to Implement Integrated Physician Education and Communication Programs CRANFORD, N.J., June 24 /PRNewswire/ -- HumaScan Inc. (Nasdaq: HMSC - news), the manufacturer and marketer of the BreastAlert(TM) Differential Temperature Sensor (''DTS''), an adjunctive medical device, today announced that it has retained Physicians World Communications Group (''PW''), based in Secaucus, N.J., to implement an integrated education and communications program to accelerate the acceptance of BreastAlert DTS among physicians. PW is recognized as a leader in developing medical education and strategic communications programs to support the launch of new pharmaceuticals and medical devices. Elizabeth E. Tallett, acting President and Chief Executive Officer commented, ''After reviewing HumaScan's marketing practices, the Company determined that a comprehensive physician education program on BreastAlert is required and I am pleased that PW is assisting us in this task. Going forward we believe that by building an informed constituency among medical opinion leaders we will accelerate the overall acceptance of BreastAlert DTS and increase its penetration. As we have said before, there is strong interest in BreastAlert DTS, and although our new strategy will take time to implement, we believe it will translate into significant sales.'' The Company also announced that a professional detailing force with a contract sales organization will be utilized to detail the product to physicians. Physician Sales & Service, Inc. will continue to be the exclusive distributor of the BreastAlert DTS. The Company further announced that effective June 22, 1998, Don Brounstein, Director and the former President and Chief Executive Officer of HumaScan, has resigned from the Board of Directors for personal reasons. Ms. Tallett commented, ''As the founder of HumaScan, Don has been instrumental in the growth of this Company and in the launch of BreastAlert DTS. We appreciate his many contributions to HumaScan over the years and wish him well in his future endeavors.'' The BreastAlert DTS is to be used by physicians as an adjunct to routine physical examination including palpation, mammography and other established procedures for the detection of breast disease. This release contains ''forward-looking statements'' which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that known and unknown risks, uncertainties and other factors may cause actual results, performance or achievements of HumaScan to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that might cause such differences include HumaScan's limited operating history and anticipated future losses, risks and uncertainties related to HumaScan's future profitability and ability to meet its capital needs, government regulation, competition, market acceptance and other factors discussed under the heading ''Risk Factors'' in HumaScan's annual report on Form 10-KSB filed with the Securities and Exchange Commission. SOURCE: HumaScan Inc. More Quotes and News: HumaScan Inc (Nasdaq:HMSC - news) Related News Categories: medical/pharmaceutical